Lucia Reinoso
Directeur Financier/CFO chez Advanced Marker Discovery SL
Postes actifs de Lucia Reinoso
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Advanced Marker Discovery SL
 Advanced Marker Discovery SL Medical SpecialtiesHealth Technology Advanced Marker Discovery SL is a holding company engaged in the development of diagnostic solutions in the field of oncology. Its pipeline consists of tests for the prognosis and prediction of colon, lung, and prostate cancer. The company was founded on June 29, 2010 and is headquartered in Valladolid, Spain. | Directeur Financier/CFO | - | - |
Historique de carrière de Lucia Reinoso
Anciens postes connus de Lucia Reinoso
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Vivia Biotech SL
 Vivia Biotech SL BiotechnologyHealth Technology Vivia Biotech SL provides biotechnology research services and laboratory instruments. It is a research and development company that focuses on the drug effects on hematological cancer patients. The firm provides personalized medicine test for blood cancers that can help predict the patient's response to treatment prior to its administration. The company was founded by Juan Antonio Ballesteros Nobell, Andrés Ballesteros Nobell and Fernando Rodríguez de Fonseca in September 2007 and is headquartered in Tres Cantos, Spain. | Directeur Financier/CFO | - | - |
Formation de Lucia Reinoso
| Instituto de Empresa SL | Masters Business Admin |
| Universidad Pontificia Comillas | Graduate Degree |
Statistiques
Internationale
| Espagne | 5 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Vivia Biotech SL
Vivia Biotech SL BiotechnologyHealth Technology Vivia Biotech SL provides biotechnology research services and laboratory instruments. It is a research and development company that focuses on the drug effects on hematological cancer patients. The firm provides personalized medicine test for blood cancers that can help predict the patient's response to treatment prior to its administration. The company was founded by Juan Antonio Ballesteros Nobell, Andrés Ballesteros Nobell and Fernando Rodríguez de Fonseca in September 2007 and is headquartered in Tres Cantos, Spain. | Health Technology |
Advanced Marker Discovery SL
Advanced Marker Discovery SL Medical SpecialtiesHealth Technology Advanced Marker Discovery SL is a holding company engaged in the development of diagnostic solutions in the field of oncology. Its pipeline consists of tests for the prognosis and prediction of colon, lung, and prostate cancer. The company was founded on June 29, 2010 and is headquartered in Valladolid, Spain. | Health Technology |
- Bourse
- Insiders
- Lucia Reinoso
- Expérience
